1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylic acid
![]() |
- $330 - $1837
- Product name: 1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylic acid
- CAS: 1226167-76-5
- MF: C11H9FN2O2
- MW: 220.2
- EINECS:
- MDL Number:MFCD16311034
- Synonyms:1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylic acid;1H-Pyrazole-3-carboxylic acid, 1-(3-fluorophenyl)-5-methyl-
4 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- TRC
Package
- 100mg
- 1g
- 2.5g
- ManufacturerAK Scientific
- Product number3387DQ
- Product description1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicacid
- Packaging1g
- Price$985
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number3387DQ
- Product description1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicacid
- Packaging2.5g
- Price$1837
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11323168
- Product description1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicacid 97%
- Packaging1g
- Price$548
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB435565
- Product description1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicAcid
- Packaging100mg
- Price$330
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 3387DQ | 1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicacid | 1g | $985 | 2021-12-16 | Buy |
AK Scientific | 3387DQ | 1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicacid | 2.5g | $1837 | 2021-12-16 | Buy |
Crysdot | CD11323168 | 1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicacid 97% | 1g | $548 | 2021-12-16 | Buy |
TRC | B435565 | 1-(3-Fluorophenyl)-5-methyl-1H-pyrazole-3-carboxylicAcid | 100mg | $330 | 2021-12-16 | Buy |
Properties
Boiling point :389.1±32.0 °C(Predicted)
Density :1.33±0.1 g/cm3(Predicted)
pka :3.90±0.10(Predicted)
Density :1.33±0.1 g/cm3(Predicted)
pka :3.90±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|